Refactor Capital Founded 2016
Founders David Lee Zal Bilimoria
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 57
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 33
Rounds per year 6.60
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 4
Stages of investment
Early Stage Venture
Seed
Areas of investment
Biotechnology
Health Care
Lifestyle
Marketing
Software
Summary

Refactor Capital appeared to be the VC, which was created in 2016.

The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2017. Speaking about the real fund results, this VC is 17 percentage points less often commits exit comparing to other organizations. When the investment is from Refactor Capital the average startup value is 500 millions - 1 billion dollars. The fund is constantly included in 7-12 deals per year.

Besides them, we counted 3 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Refactor Capital, startups are often financed by Soma Capital, FundersClub, First Round Capital. The meaningful sponsors for the fund in investment in the same round are Soma Capital, Fifty Years, Slow Ventures. In the next rounds fund is usually obtained by Y Combinator, KdT Ventures, iSELECT FUND.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Clover Health, Finova Financial, Solugen The fund has exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Health Care, Software.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
PathAI
Health Care
Health Diagnostics
Late Stage Venture
165M18 May 2021 United States, Boston
Brave Care
Children
Health Care
Early Stage Venture
10M22 Apr 2021 United States, Portland
Mori
AgTech
Food and Beverage
Food Processing
Early Stage Venture
16M15 Apr 2021 United States, Boston
Late Stage Venture
250M14 Apr 2021
Orchid
Biotechnology
Health Care
Medical
mHealth
Seed
4M07 Apr 2021 United States, San Francisco
Rubedo Life Sciences
Biotechnology
Health Care
Seed
12M03 Dec 2020 United States, Sunnyvale
ANA Therapeutics
Biotechnology
Clinical Trials
Emergency Medicine
Health Care
Medical
Therapeutics
Seed
5M04 Aug 2020 United States, " United States"}
Mori
AgTech
Food and Beverage
Food Processing
Early Stage Venture
12M17 Jul 2020 United States, Boston
Magic
Apps
Artificial Intelligence
B2B
Customer Service
Messaging
Mobile
Outsourcing
Task Management
Virtual Assistant
Seed
4M29 May 2020 United States, San Francisco
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Refactor Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: